Fatigue with vascular endothelial growth factor receptor tyrosine kinase inhibitors and mammalian target of rapamycin inhibitors in patients with renal cell carcinoma (RCC) and other malignancies: A meta-analysis of randomized clinical trials

Pooja Ghatalia, Youjin Je, Paul L. Nguyen, Quoc Dien Trinh, Toni K. Choueiri, Guru Sonpavde

Hematology Oncology
Nuclear Dynamics and Cancer (NDC)
Cancer Epigenetics Institute

Kyung Hee University
Brigham and Women's Hospital
Harvard University
Dana-Farber Cancer Institute
Dana-Farber/Brigham and Women's Cancer Center
Cancer Center
Dana-Farber/Harvard Cancer Center
University of Alabama at Birmingham
University of Central Florida

Research output: Contribution to journal › Review article › peer-review

8 Scopus citations

Fingerprint

Dive into the research topics of 'Fatigue with vascular endothelial growth factor receptor tyrosine kinase inhibitors and mammalian target of rapamycin inhibitors in patients with renal cell carcinoma (RCC) and other malignancies: A meta-analysis of randomized clinical trials'. Together they form a unique fingerprint.

Sort by
Weight
Alphabetically

Fatigue with vascular endothelial growth factor receptor tyrosine kinase inhibitors and mammalian target of rapamycin inhibitors in patients with renal cell carcinoma (RCC) and other malignancies: A meta-analysis of randomized clinical trials

Fingerprint

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science